SUMMARY -Th e aim of this prospective study was to detect primary open angle glaucoma (POAG) in its early stage in patients at a higher risk of its development, and to identify the risk group with the highest prevalence of POAG. Th e study was conducted at Department of Ophthalmology, Osijek University Hospital Centre, and included 250 patients divided into fi ve groups, as follows: group 1, patients with diabetes type 1 and type 2; group 2, patients with arterial hypertension (blood pressure >140/90 mm Hg); group 3, patients with positive family history of POAG; group 4, patients with myopia between -3.0 and -8.0 diopters; and group 5, control group including patients aged 40 with no risk factors for POAG development. Study results showed that distribution of glaucoma patients was not equal across the groups. Th e prevalence of POAG in all patients was 5.6%, whereas in patients with positive family history of POAG it was 14%, which was statistically signifi cantly higher than in patients with diabetes and myopia (4% both), as well as in control group. Th e diff erence was greatest in comparison to control group. Th ere was no statistically signifi cant diff erence in glaucoma incidence between the group of patients with positive family history (14%) and patients with systemic hypertension (6%). Th e results obtained suggest that of all risk factors analyzed, positive family history of POAG is the most important risk factor for glaucoma development in all risk groups.
Introduction
Glaucoma is the second leading cause of blindness worldwide. Primary open angle glaucoma (POAG) affects about 2% of the world population aged 40 and older, only half of them being aware of having the disease and even less receiving appropriate therapy. It is therefore not surprising that there are about 7 million people blind on both eyes as the result of glaucoma 1, 2 . Early detection of POAG and appropriate therapy can slow down the progression and sometimes arrest development of the disease. Th us, it is of utmost importance to defi ne the risk factors contributing to disease development.
Th e best-known risk factor for glaucomatous optic neuropathy (GON) is increase in the intraocular pressure (IOP). Apart from increased IOP, other possible risk factors are old age, family history of glaucoma, diabetes, cardiovascular diseases, systemic hypertension and hypotension, vasospastic syndromes [3] [4] [5] and myopia (especially myopia of 6.0 or more diopters) 6, 7 . Taking into account the high incidence of primary glaucoma within families, it has been determined that the risk of glaucoma development is 3 to 6 times higher in fi rst-degree relatives than in the general population. Up to the present, 17 genes have been identifi ed that can play a signifi cant role in glaucoma pathogenesis. Th e gene for POAG has been identifi ed on chromosome 1q, where the Trabecular meshwork Induced Glucocorticoid Response protein (TIGR) gene is also mapped. TIGR gene mutation is responsible for increased IOP by obstruction of the aqueous humor outfl ow channel.
Patients with diabetes are at a moderate risk of developing POAG (about 5.5%) 8, 9 . Th e lowest positive correlation for glaucoma development was determined in patients with systemic hypertension (3%) 10, 11 , patients with migraine headaches and vasospasm and hypotension episodes.
Numerous studies have shown that there is a greater risk of developing glaucoma in patients with moderate to high myopia. A study carried out in Sweden on more than 32,000 patients has confi rmed that myopia is a signifi cant risk factor for glaucoma development 12 . Increased axial length and lesser corneal thickness in myopic patients results in decreased retinal microcirculation, which may contribute to glaucoma development.
Th e aims of this study were to detect POAG in its early stage in patients at a higher risk of its development and to determine the risk group with the highest incidence of glaucoma.
Subjects and Methods
Th e study included four risk groups with 50 patients each, all of them aged over 40, and 50 patients as a control group. Group 1 included patients with diabetes type 1 and type 2 with no proliferative diabetic retinopathy; group 2 included patients with arterial hypertension but with no retinal hemorrhage or edema, whereby hypertension was defi ned as systolic pressure of 140 mm Hg or higher, and diastolic pressure of 90 mm Hg or higher; group 3 included patients with a family history of POAG who had not been previously diagnosed and had not received any anti-glaucoma therapy; group 4 included patients with myopia between -3.0 and -8.0 diopters; and control group included patients aged over 40 who did not belong to any risk group for developing POAG.
Th is research was conducted at Department of Ophthalmology, Osijek University Hospital Centre in Osijek. Th e patients included in the study were referred to general ophthalmology examination by their family physicians. Central visual acuity on both eyes was better than 0.3 with or without correction in all study patients.
Th e sample size of 140 patients was determined to be suffi cient to estimate the prevalence of glaucoma with a 95% confi dence interval (95%CI), assuming the prevalence rate of 10%.
Exclusion criteria were as follows: patients who had already been diagnosed with glaucoma and IOP; and patients who had already received anti-glaucoma therapy.
Medical history was taken in all patients, followed by clinical examination and the following diagnostic procedures:
• central visual acuity was determined using Snellen optotypes; 
Statistical analysis
Th e data obtained were systematized as variables of nominal type. Correlation between the results of diagnostic procedures and the patient category was tested by comparing p-values applying χ 2 -test and Fisher exact test, depending on data. Th e signifi cance level was defi ned as α=0.05. Statistical analysis was done by SAS 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Statistical analysis of the patients (applying χ 2 -test) in the risk groups based on the parameters defi ning glaucoma showed that distribution of patients with glaucoma was not equal in diff erent risk groups. Comparison of p-values showed that the prevalence of POAG in patients with a family history of primary simplex glaucoma was statistically signifi cantly greater than in the groups of patients with diabetes and myopia, as well as in the control group. Th e diff erence was greatest in relation to the control group. Th ere was no statistically signifi cant diff erence in the prevalence of glaucoma between the groups of patients with a family history and patients with systemic hypertension (Fig. 1) .
In patients with diabetes, the prevalence of POAG was 4%, which was not statistically signifi cant in relation to the control group (p=0.078 vs. defi ned signifi cance level of p<0.05). Th ese results are shown in Figure 2 .
In patients with systemic hypertension, the POAG prevalence was 6%, which was statistically signifi cant in relation to the control group (p=0.04, which was less than the defi ned signifi cance level of p<0.05). Th ese results are shown in Figure 3 .
In patients with a family history, the POAG prevalence was 14%, which was statistically more signifi cant than in the control group (p=0.0036 in comparison to defi ned signifi cance level of p<0.05), and also statistically more signifi cant than in the groups of patients with myopia and diabetes (p=0.04 in both groups, which was less than defi ned signifi cance level of p<0.05) (Fig. 4) . Th e results of this research showed that, based on the set variables, not a single case of POAG was detected in the control group (Fig. 5 ).
Discussion
Patients with diabetes are at a moderate risk of developing POAG. Th e possible pathogenetic sequence is disturbed microcirculation in the optic nerve head and changes of glial and neuronal activity, as well as in metabolism of the retina 13 , which can lead to apoptosis of retinal ganglion cells. Th us, diabetes may cause damage to neuronal metabolism and to retinal glia, which may further result in hypersensitivity of these cells to stress, as well as in the possible increase in IOP. Th is brings diabetes in direct positive correlation with development of glaucoma damage to the optic nerve.
In diabetic patients included in this research, the prevalence of POAG was 4%, which was not statistically signifi cant in relation to the control group (p=0.078 and p<0.05, respectively). Th ese results are similar to those obtained in the Framingham Eye Study 14 and Baltimore Study 15 , according to which diabetes and POAG did not show signifi cant correlation. Furthermore, the Collaborative Glaucoma Study also confi rmed that there was no signifi cant correlation between diabetes and POAG 16 . However, in the Rotterdam Study, where the same parameters as in our study were used (visual fi eld damage, C/D ratio and IOP greater than 21 mm Hg), the prevalence of developing POAG in patients with diabetes was three times higher than in other studies 17 . Numerous studies have confi rmed the signifi cance of vascular factors and hypertension for development of glaucoma. Th e Collaborative Normal Tension Glaucoma Study showed that disc hemorrhage in patients with frequent migraine headaches and vasospasms was an important factor contributing to glaucoma progression 18 . Looped/coiled peripapillary blood vessels, peripapillary retinal nerve fi ber layer (RNFL) thinning, and arteriolar stenosis are the areas with greatest visual fi eld loss 19 . Th e Baltimore Study showed that increased systemic pressure may have a protective role only in the initial stage of glaucoma development, whereas in the later stage it stimulates glaucoma progression, mainly because it usually aff ects elderly people who already suff er from atherosclerosis, which directly disturbs ocular perfusion pressure and blood fl ow autoregulation 11 . To preserve hemodynamic balance in the optic disc, it is necessary to maintain blood fl ow autoregulation, which means that whenever there is an increase in IOP, peripheral vascular resistance decreases or the pressure in the ophthalmic artery increases [20] [21] [22] . Despite the fact that some studies have shown positive correlation between IOP values and systemic blood pressure values, it was not confi rmed in a large population study (Baltimore Eye Survey). Some facts are contradictory. Namely, the same study confi rmed great and statistically signifi cant correlation between untreated systemic hypertension and glaucoma on the one hand, while on the other hand, the patients treated for hypertension included in the same study were not at a higher risk of developing glaucoma than the control group. It seems logical that increased systemic pressure damages capillary circulation and thus decreases optic disc perfusion, but from the physiological aspect these contradictory facts lead to the conclusion that systemic hypertension represents a low risk for development of glaucoma.
Positive family history of POAG correlates positively with more severe clinical symptoms of POAG, which is defi ned as increased vertical C/D ratio. However, in some studies, positive family history did not correlate with the degree of visual fi eld damage. Th us, in the study by Landers et al. 23 , it was concluded that positive family history of POAG did not have any infl uence on the progression of glaucoma. Namely, they confi rmed that positive family history of POAG correlated with better results in visual fi eld test in patients under the age of 50, but not in older ones.
In the group of patients with a family history of POAG included in this study, 14% of patients were fi rst diagnosed with POAG, which was statistically more signifi cant than in the control group (p=0.0036 and p<0.05, respectively), and also statistically more signifi cant than in the groups of patients with myopia and diabetes. Th is relatively high of prevalence POAG in the group with positive family history corresponds to the results obtained in other studies, where the prevalence is between 13% and 25% 24, 25 . Th is high percentage leads to the conclusion that positive family history represents the greatest risk factor for development of glaucoma compared to other factors analyzed in all risk groups. It is well known that in one-sixth of all glaucoma cases, there is a positive family history. Th e risk of glaucoma development is almost 10 times higher in fi rst-degree relatives than in control groups 26 . Also, some studies confi rmed that the fi rst-degree relatives of patients with POAG had a 42.5% higher risk of increased IOP than patients in the control group, increased C/D ratio was 62.2% in comparison to 16.6% in the control group, and the risk of glaucoma development was 22.0% in comparison to 2.3% in the control group 26 . Th is positive correlation between family history and POAG development may be explained by the fact that two of the variables taken into account for diagnosing glaucoma (IOP and C/D ratio) are genetically determined 27 . Even though the mechanisms regarding myopia and glaucoma development are still insuffi ciently explained, it is assumed that the optic nerve head in myopic eyes is structurally more sensitive to glaucoma damage due to structural changes in connective tissue 28, 29 . Some studies show that the risk of developing glaucoma is proportional to myopia degree. According to Mitchell et al. in the Blue Mountains Eye Study, the odds ratio for glaucoma development was 2.3 in low myopia and 3.3 in moderate to high myopia 30 . Th e prevalence of POAG in patients with myopia in our study was 4%, which was not statistically signifi cant in relation to the control group (p=0.0782 and p<0.05, respectively). Daubs and Crick also confi rmed greater prevalence of POAG in patients with myopia 31 .
Conclusion
Early diagnosis of glaucoma is primarily based on morphological analysis of the optic nerve head, IOP and CCT measurement, as well as on the analysis of visual fi eld progression applying up-to-date functional tests. Histologic studies have confi rmed that significant loss of RNFL and optic nerve fi bers occurs prior to functional vision fi eld losses measurable by current diagnostics. Unfortunately, technology that could detect the disease in its initial stages does not exist. One of the reasons is certainly the fact that the etiopathology of the disease has not yet been completely explained. Th is study confi rmed the signifi cance of doing early screening in risk groups of patients in order to detect glaucoma as early as possible. Only early diagnosis and timely treatment can prevent development of permanent complications that will result in blindness.
